Functional Technologies (OTC Other: FEBTF; TSX-V: FEB), according to its CEO, Howard Louie, “has accomplished significant achievements in the past year, particularly in building technical and commercial value for our proprietary acrylamide-preventing (“AP”) yeast platform. This extends from demonstrating compelling efficacy data, to the cultivation of strategic relationships with multiple tier one and tier two yeast producers as well as an increasing range of food processing end users. Our corporate goal to drive technologies from bench to commercialization is being realized with our H2S-preventing wine yeasts, achieving increasing market presence through significant growth in the number of wineries purchasing introductory quantities of our product with results that reflect a strong market interest across several new regional markets. Meanwhile, our technical research and development team continue to improve and increase the quality and breadth of our wine yeast product offering to fulfill our goals to develop and increase market share while establishing the business model of our technology as a platform.”
Functional Technologies Year End Update
Advertisement
